title: Extreme thrombocytosis in response to PEG-ADA: early therapeutic and risk indicator.
authors.affiliation: School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
authors.forename: V R
authors.initials: VR
authors.lastname: Marwaha
authors.forename: D H
authors.initials: DH
authors.lastname: Italia
authors.forename: F
authors.initials: F
authors.lastname: Esper
authors.forename: R W
authors.initials: RW
authors.lastname: Hostoffer
mesh_terms: D000243:Adenosine Deaminase / Q000009:adverse effects* / Q000172:deficiency / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D016511:Severe Combined Immunodeficiency / Q000175:diagnosis / Q000188:drug therapy*; D013922:Thrombocytosis / Q000139:chemically induced*
chemical_list: D000243:Adenosine Deaminase; C051409:pegademase bovine